A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling
Description
Altered myeloid inflammation and lymphopenia are hallmarks of severe infections. We identified the upregulated EN-RAGE gene program in airway and blood myeloid cells from patients with acute lung injury from SARS-CoV-2 or other causes across 7
